New medical therapies on the horizon: oral octreotide

Somatostatin analog treatment is first line medical treatment in patients with acromegaly. This drug is currently mainly administered by monthly depot preparations of octreotide and lanreotide. With the innovative transient permeability enhancer, a technology enabling the absorption of drug molecule...

Descripción completa

Detalles Bibliográficos
Autor principal: Biermasz, Nienke R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5334421/
https://www.ncbi.nlm.nih.gov/pubmed/28091879
http://dx.doi.org/10.1007/s11102-016-0785-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5334421/
https://www.ncbi.nlm.nih.gov/pubmed/28091879
http://dx.doi.org/10.1007/s11102-016-0785-3

Ejemplares similares